RAYMOND JAMES & ASSOCIATES - FOGHORN THERAPEUTICS INC ownership

FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 64 filers reported holding FOGHORN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of FOGHORN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,131,130
-14.9%
1,426,226
+19.8%
0.01%
-14.3%
Q2 2023$8,384,563
+25.4%
1,190,989
+10.5%
0.01%
+16.7%
Q1 2023$6,683,947
+92.3%
1,078,056
+97.8%
0.01%
+100.0%
Q4 2022$3,476,673
+1290.7%
544,933
+1770.2%
0.00%
Q3 2022$250,000
-34.7%
29,137
+3.6%
0.00%
Q2 2022$383,000
-3.8%
28,137
+7.7%
0.00%
Q1 2022$398,000
+34.5%
26,137
+102.0%
0.00%
Q4 2021$296,00012,9370.00%
Other shareholders
FOGHORN THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Euclidean Capital LLC 1,261,261$16,623,0005.56%
Flagship Pioneering Inc. 12,674,120$167,045,0002.68%
Birchview Capital, LP 314,143$4,140,0002.46%
Monashee Investment Management LLC 530,581$6,993,0001.08%
Artal Group S.A. 1,720,720$22,679,0000.40%
Octagon Capital Advisors LP 69,132$911,0000.34%
Cormorant Asset Management, LP 1,000,000$13,180,0000.29%
Alphabet Inc. 500,901$6,602,0000.27%
Casdin Capital, LLC 216,216$2,850,0000.08%
Board of Trustees of The Leland Stanford Junior University 30,657$404,0000.04%
View complete list of FOGHORN THERAPEUTICS INC shareholders